Colombat, P <br/><br/>
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Sep 2012 
 - 2380-2385 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mds177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunization, Passive<br/>Induction Chemotherapy<br/>Kaplan-Meier Estimate<br/>Lymphoma, Follicular--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Rituximab<br/>Treatment Outcome